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We describe the characterization of influenza A virus infection of an established in vitro model of human
pseudostratified mucociliary airway epithelium (HAE). Sialic acid receptors for both human and avian viruses,
-2,6- and -2,3-linked sialic acids, respectively, were detected on the HAE cell surface, and their distribution
accurately reflected that in human tracheobronchial tissue. Nonciliated cells present a higher proportion of
-2,6-linked sialic acid, while ciliated cells possess both sialic acid linkages. Although we found that human
influenza viruses infected both ciliated and nonciliated cell types in the first round of infection, recent human
H3N2 viruses infected a higher proportion of nonciliated cells in HAE than a 1968 pandemic-era human virus,
which infected proportionally more ciliated cells. In contrast, avian influenza viruses exclusively infected
ciliated cells. Although a broad-range neuraminidase abolished infection of HAE by human parainfluenza
virus type 3, this treatment did not significantly affect infection by influenza viruses. All human viruses
replicated efficiently in HAE, leading to accumulation of nascent virus released from the apical surface between
6 and 24 h postinfection with a low multiplicity of infection. Avian influenza A viruses also infected HAE, but
spread was limited compared to that of human viruses. The nonciliated cell tropism of recent human H3N2
viruses reflects a preference for the sialic acid linkages displayed on these cell types and suggests a drift in the
receptor binding phenotype of the H3 hemagglutinin protein as it evolves in humans away from its avian virus
precursor.
Influenza A viruses cause illness and raised mortality rates in
susceptible populations every winter and significantly increase
disease burden during pandemic periods, which have occurred
at irregular and unpredictable intervals during the last century.
The most recent pandemic in 1968 was due to the introduction
of a new influenza subtype (H3N2) into the human population.
The H3N2 pandemic virus was produced by a reassortment
event between the H2N2 influenza subtype that had previously
been circulating in the human population and an avian influ-
enza virus. Six gene segments from the H2N2 human strain,
including the N2 neuraminidase (NA) gene, combined with the
H3 hemagglutinin (HA) and PB1 genes acquired from an avian
virus source. The resulting virus with its novel avian HA pro-
tein caused widespread infection in the immunologically naive
human population (14, 34).
The first stage in influenza virus entry to a host cell is rec-
ognition of terminal sialic acid on glycosylated cell surface
molecules by the viral HA protein. HA receptor specificity is
host species dependent such that human influenza viruses bind
via HA to receptor molecules bearing -2,6-linked sialic acid
while avian strains preferentially bind to -2,3-linked sialic acid
(31). A single amino acid change in the HA1 subunit from
glutamine to leucine at position 226 has been shown to switch
the preference from -2,3- to -2,6-linked sialic acid (32), and
this mutation is critical in the early adaptation of avian virus
HA to humans (4, 20, 25).
In humans, influenza A viruses are primarily respiratory
pathogens targeting cells in the respiratory epithelium of the
human airway. Early work to identify the cell type targeted by
human influenza viruses showed virus binding to the ciliated
respiratory epithelium, which displayed the appropriate -2,6-
linked sialic acid receptors in preference to mucin-producing
goblet cells containing -2,3-linked sialic acid (3, 6). More
recently, Matrosovich and coworkers demonstrated that the
initial cell target of human influenza viruses in a cell culture
model of the human airway epithelium is the nonciliated cell
type while, in contrast, influenza viruses from avian species
infect ciliated cells, and this reflects the distinct expression of
sialic acid linkages on nonciliated (-2,6) and ciliated (-2,3)
cells, respectively (21).
Respiratory viruses such as influenza virus must surmount
obstacles in the human airway to reach the cells of the ciliated
respiratory epithelium, where infection and replication occur.
The mucociliary epithelium presents a physical barrier in terms
of active cilial function and the presence of a complex array of
glycocalyx components such as tethered and soluble mucins
displaying sialyloligosaccharides, which can function as false
receptors impeding virus delivery to the surface of the epithe-
lium. In addition, the availability of appropriate receptor mol-
ecules on the apical cell surface also drives evolution of the
virus-receptor interaction and adaptation to the human host.
The importance of the array of sialyloligosaccharides pre-
sented on the human airway epithelium in the selection of HA
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receptor specificity is suggested by the shift in receptor speci-
ficity in human viruses compared to that in their avian progen-
itors (20, 31). The abundance of -2,6-linked sialic acid on the
ciliated epithelium provides a selective pressure for viruses
infecting humans to evolve a receptor preference for this sialic
acid linkage (9).
Since the 1968 pandemic, the H3N2 subtype has become
established in the human population, evolving in the new host
subject to immune selective pressure. The addition of glycosy-
lation to HA has been described as a mechanism for antigenic
drift and consequent virus escape from antibody binding by
shielding antigenic sites on the globular head of the molecule
(1). The additional glycosylation can also decrease receptor
binding activity, presumably due to occlusion of the receptor
binding site pocket (1, 27). Evolution of influenza A viruses in
humans has brought about changes in receptor binding speci-
ficity and affinity; specifically, it has been observed that recent
H1N1 and H3N2 clinical isolates no longer agglutinate chicken
red blood cells (2, 22, 24, 26, 37). The fine receptor binding
specificity of human influenza viruses is beginning to be un-
derstood, and indeed, a new preference of modern H3N2 iso-
lates for binding Neu5Ac2,6Gal1-4GlcNAc (6SLN) over
Neu5Ac2,6Gal1-4Glc (6SL) was recently described (23).
Therefore, although a major change in receptor binding spec-
ificity occurs early in the adaptation of influenza virus to hu-
mans, the interaction of HA with its sialic acid receptor is
constantly evolving.
In this study, we describe the cell tropism of recent H3N2
influenza viruses compared to a human H3N2 virus closely
related to the 1968 pandemic strain and avian influenza vi-
ruses. Using a well-characterized in vitro model of the human
airway epithelium (43, 44), we found that recent H3N2 viruses
infect a higher proportion of nonciliated cells than an early
H3N2 influenza virus, which, like avian influenza strains, pref-
erentially infected ciliated cells. The evolving preference from
ciliated cells toward the nonciliated cell type reflects the major
distribution of -2,6-linked sialic acid, the receptor for human
viruses, on this cell type.
MATERIALS AND METHODS
Influenza A viruses. Influenza A H3N2 human viruses were selected from a
larger panel of clinical isolates that has previously been characterized and that
represents the evolutionary span of the virus in humans from 1968 to the present
day (37). Viruses were obtained from archives at the Health Protection Agency
(HPA) Centre for Infections, Colindale, London, United Kingdom. Archived
samples that had been passaged in cell culture from the original respiratory
sample before storage at 80°C were selected and amplified by two to three
passages in MDCK cells. Infectious supernatants were stored at 80°C and
thawed immediately before use. Avian influenza viruses A/Duck/England/62
(H4N6), A/Duck/Ukraine/1/63 (H3N8), and A/Duck/Singapore/5/97 (H5N3)
were originally obtained from the HPA collection held at Colindale and have
been extensively passaged in MDCK cells and in eggs. The construction of
PIV3-GFP has been described previously (43).
Cell lines for virus titration. MDCK cells were routinely passaged in Dulbec-
co’s modified Eagle’s medium (DMEM; Gibco, New York) with L-glutamine,
sodium pyruvate, and pyridoxine hydrochloride supplemented with 10% fetal
bovine serum (Atlanta Biologicals, Georgia) and penicillin-streptomycin (Gibco,
New York).
HAE cell cultures. Human airway tracheobronchial epithelial cells were ob-
tained from airway specimens resected at lung transplantation under UNC In-
stitutional Review Board-approved protocols by the UNC Cystic Fibrosis Center
Tissue Culture Core. Briefly, primary cells derived from single patient sources
were expanded on plastic to generate passage 1 cells and plated at a density of
250,000 cells per well on permeable Transwell-Col (12-mm diameter) supports.
Human airway epithelium (HAE) cultures were generated by provision of an
air-liquid interface for 4 to 6 weeks to form well-differentiated, polarized cultures
that resemble in vivo pseudostratified mucociliary epithelium as previously de-
scribed (30). Cultures were derived from patients without underlying lung dis-
ease.
Viral inoculation of HAE. Human and avian influenza A viruses were diluted
with phosphate-buffered saline (PBS) to equal titers, as determined by a 50%
tissue culture infective dose (TCID50) assay of MDCK cells. HAE cells were
washed extensively with PBS to remove mucus secretions on the apical surface
prior to infection with a low multiplicity of infection (MOI) (0.1 to 0.01) of
influenza virus in a 100-l inoculum. Virus was removed from the apical surface
following a 1-h incubation at 37°C, and the cells were then incubated at 37°C for
a further 6 to 48 h as required. Viruses released into the apical compartment of
HAE were harvested by the apical addition and collection of 300 l of medium
allowed to equilibrate at 37°C for 30 min. Samples were stored at 80°C. Viral
titer was determined by a hemagglutination assay and a TCID50 assay. Cultures
were washed with PBS and fixed with 4% paraformaldehyde before histological
sections of the airway epithelium were prepared by the UNC Cystic Fibrosis
Center Histology Core using standard techniques.
Hemagglutination assay. Hemagglutination assays were carried out in V-
bottomed microtiter plates using 50 l of 0.5% suspensions of turkey red blood
cells in PBS (Valley Biomedical, Winchester, VA) added to 50 l virus serially
diluted in PBS. Assays were read following a 1 h-incubation on ice.
Viral titration by TCID50 assay. MDCK cells were seeded on 96-well plates
and infected the following day for 1 h at 37°C with log or half-log dilutions of
virus in serum-free media. Viral inoculum was removed and replaced with se-
rum-free DMEM plus 1 g/ml TPCK L-(tosylamido-2-phenyl) ethyl chlorom-
ethyl ketone)-treated trypsin (Worthington Biochemical Corporation, New Jer-
sey) and incubated at 37°C for 3 days. Cell monolayers were fixed and stained
with crystal violet-methanol, and TCID50/0.1-ml values were calculated using the
Spearman-Karber formula.
Immunolocalization of epithelial cell carbohydrate components and viral gly-
coproteins. Standard protocols were used for lectin- and antibody-based local-
ization of target antigens and terminal sialic acids on HAE and paraformalde-
hyde-fixed, paraffin-embedded histological cross sections of HAE and excised
lung tissue. Lectin staining was performed with Sambucus nigra agglutinin (SNA;
Vector Laboratories) for sialic acid -2,6 linked to galactose and Maackia amu-
rensis agglutinin (MAA; EY Laboratories) for sialic acid -2,3 linked to galac-
tose. Lectins were conjugated to biotin linkers, and a streptavidin conjugate of
Alexa Fluor 488 (Molecular Probes) was used to detect lectin binding.
Histological cross sections were blocked with 3% bovine serum albumin/PBS
and probed with anti--tubulin IV mouse monoclonal antibody (Sigma-Aldrich),
followed by goat anti-mouse immunoglobulin G (IgG) conjugated to Alexa Fluor
594 (Molecular Probes) to identify ciliated cell types of HAE.
For localization of influenza A proteins in HAE, en face staining with mouse
anti-influenza A nucleoprotein (Serotec) and goat anti-mouse IgG conjugated to
Alexa Fluor 488 (Molecular Probes) was performed.
For localization of influenza A proteins in histological cross sections of HAE,
sections were blocked with 3% bovine serum albumin/PBS, stained with rabbit
polyclonal anti-influenza A H3N2 serum (R372 raised against A/England/24/94
at HPA, Colindale) or rabbit polyclonal antibody to avian influenza nucleopro-
tein (Imgenex), and costained with anti--tubulin IV mouse monoclonal anti-
body (Sigma-Aldrich) to identify infected ciliated cells. Goat anti-rabbit IgG
conjugated to fluorescein isothiocyanate (FITC; Jackson ImmunoResearch
Labs) or anti-rabbit FITC (Oxford Biotechnology, United Kingdom) and goat
anti-mouse conjugated to Alexa Fluor 594 or anti-mouse Texas Red (Calbio-
chem) were used for detection. Slides were mounted in VectorShield (Vector
Labs) mounting medium for fluorescence with DAPI (4,6-diamidino-2-phe-
nylindole). Photomicrographs were acquired using a Leica Leitz DMIRB in-
verted fluorescence microscope equipped with a cooled-color charge-coupled
device digital camera (MicroPublisher; Q-Imaging). Infected cells were quanti-
fied using the Image Processing Tool Kit plug-ins for Photoshop (ISBN no.
1-928808-00-X; John C. Russ).
Neuraminidase treatment of HAE. The apical surfaces of HAE cultures were
washed extensively (10 times) with PBS prior to treatment with neuraminidase
(160 mU/ml) from Vibrio cholerae (Sigma) for 3 h at 37°C. Control cultures
(without NA) were incubated with serum-free DMEM only. The neuraminidase
was removed, and the cultures were washed three times with serum-free DMEM.
Cultures were infected via the apical surface with human H3N2 influenza virus
A/England/26/99 or PIV3-GFP (106 PFU) for 1 h at 37°C, the virus was removed,
and the surface was washed. Cultures were fixed at 24 h postinfection with
ice-cold 50:50 methanol/acetone and washed with PBS. Influenza virus-infected
cultures were stained en face with mouse anti-influenza A nucleoprotein anti-
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body (Serotec), followed by goat anti-mouse IgG conjugated to Alexa Fluor 488
(Molecular Probes).
Microscopy. Visualization of virus with transmission scanning electron micros-
copy was performed using standard techniques. HAE cultures infected with avian
(A/Duck/Singapore/5/97) and human (A/England/26/99) influenza A viruses at an
MOI of 0.1 were fixed at 12 h postinfection with perfluorocarbon-osmium tetroxide.
Sections were processed for electron microscopy and analyzed.
RESULTS
Distribution of influenza virus sialic acid receptors in HAE
correlates with that in human airway tissue. We examined the
distribution of the human influenza virus receptor, -2,6-
linked sialic acid, in cultures of human airway tracheobronchial
epithelial cells. Using the lectin SNA and costaining with anti-
-tubulin IV, we determined the distribution of -2,6-linked
sialic acid in relation to ciliated cells. Staining for SNA was
abundant on the apical surface of nonciliated cells and partic-
ularly concentrated at a level corresponding to the microvilli
(Fig. 1A). In addition, a lower level of SNA staining was also
observed on the apical surface of some ciliated cells, suggesting
that -2,6-linked sialic acid was distributed across both cell
types in HAE (Fig. 1B). To determine whether the localization
of -2,6-linked sialic acid on HAE was representative of the
distribution in ex vivo tissue samples from humans, paraffin-
embedded histological cross sections of excised human airway
tissue were stained. As for HAE, SNA staining was observed
predominantly on nonciliated cells although ciliated cells were
also stained (Fig. 1C).
We also investigated the distribution of the avian influenza
virus receptor, -2,3-linked sialic acid, on HAE and human
airway tissue sections by using the -2,3 linkage-specific lectin
MAA. Staining with MAA indicated that -2,3-linked sialic
acid was predominantly on the apical surface of ciliated cells at
the base of the cilial shaft in the region of the microvilli (Fig.
1D). Importantly, only a small proportion of ciliated cells in
HAE were stained, indicating that not every ciliated cell dis-
plays -2,3-linked sialic acid. In addition, MAA staining was
clearly found to a lesser degree on some nonciliated cells (Fig.
1D). Examination of paraffin-embedded histological cross sec-
tions of excised human airway tissue also clearly showed stain-
ing of some but not all ciliated cells with MAA (Fig. 1E).
Again, staining was observed at the immediate apical surface
of the cells below the level of the cilia and had a “brush
border” appearance, suggesting that the lectin could be local-
ized to the tips of the microvilli. Relative intensity of staining
achieved with the lectins was not used as a direct quantitative
measure of sialic acid distribution, as the relative affinities of
FIG. 1. Histological cross sections of HAE and excised human air-
way tissue samples were probed with anti--tubulin IV (red) and the
lectin (green) SNA for the human influenza virus receptor (-2,6-
linked sialic acid) or MAA for the avian influenza virus receptor
(-2,3-linked sialic acid). SNA was visible on the apical surface of
nonciliated (A) and ciliated cells (B). SNA on ciliated and nonciliated
cells was also observed in excised human airway tissue samples (C).
MAA was visible on the apical surface of ciliated cells and, to a lesser
degree, on nonciliated cells (D). MAA was observed at the apical
surface of ciliated cells in paraffin-embedded, excised human airway
tissue (E). Arrows, ciliated cells; arrowheads, nonciliated cells.
FIG. 2. Viral proteins were detected in ciliated (A and B) and
nonciliated (C and D) cells in histological cross sections of HAE
infected with recent influenza A H3N2 virus strain A/England/26/99
and fixed at 6 h postinfection with 4% paraformaldehyde. Sections
were costained with anti-influenza A H3N2 rabbit polyclonal antibody
(green) and anti--tubulin IV (red) to identify ciliated cells. Cell nuclei
were visualized with DAPI staining in VectorShield mounting medium.
Representative fluorescent photomicrographs of viral proteins local-
ized in the cell nuclei and cytoplasm are shown costained with -tu-
bulin IV and DAPI (A and C), and the same images are shown with
FITC staining only (B and D).
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the lectins, the degrees of biotinylation, or the intensities of
fluorescent conjugates may differ.
Human influenza A viruses infect both ciliated and noncili-
ated cells in HAE. HAE cultures were infected with human
strains of H3N2 influenza A virus, for example A/England/26/
99, at a low multiplicity of infection and examined for the
localization of viral proteins at 6 h postinfection during a single
cycle of viral replication. Using -tubulin IV, a marker for
ciliated cells, in conjunction with antibody against viral pro-
teins, virus was detected in both ciliated and nonciliated cell
types (Fig. 2). Intense staining of viral proteins localized in the
cell nucleus, and spreading through the cytoplasm toward the
apical cell surface was observed as early as 6 h postinfection.
The polyclonal antisera used detect predominantly nucleopro-
tein (NP) and HA viral antigens.
In previous work, we characterized a panel of human H3N2
influenza A viruses isolated between 1969 and 2000 and
showed a changing pattern of receptor binding represented by
reduced agglutination of red blood cells by recent isolates (37).
FIG. 3. (A) HAE cultures were infected with human influenza A
viruses isolated in England from 1969 to 2000 (A/England/878/69,
A/ England/26/99, and A/England/24/00 [H3N2]) and with avian
influenza A viruses (A/Duck/England/62 [H4N6], A/Duck/
Ukraine/63 [H3N8], and A/Duck/Singapore/5/97 [H5N3]) (MOI,
0.1). Histological cross sections of HAE were immunostained with
anti-influenza A H3N2 rabbit polyclonal antibody or anti-avian
influenza nucleoprotein rabbit polyclonal antibody and counter-
stained for -tubulin IV to identify ciliated cells. Viral proteins
were localized at 6 h (human viruses) postinfection in both ciliated
and nonciliated cell types, and the proportion of infected ciliated
and nonciliated cells for the older virus (1969) and more-recent
(1999 to 2000) virus strains was determined. Viral protein from
avian strains was found only at 24 h postinfection almost exclusively
in ciliated cells. Two independent experiments were performed.
The proportion of ciliated and nonciliated cell types with respect to
the total number of infected cells in three separate cross sections
(10 to 100 infected cells/section) was determined. The number of
infected cell types as a proportion of the total number of infected
cells from a representative experiment is displayed. The lower table
indicates the total number of potential glycosylation site motifs on HA
for each virus of the H3 subtype. (B) Three-dimensional structure
model of H3 HA (Protein Data Bank identification number 1HGF)
(17, 33) produced using Protein Explorer (18), indicating the position
of five new potential glycosylation sites (dark gray spacefill) on the
globular head of the HA molecule in the vicinity of the receptor
binding site. Numbers indicate Asn residues in the first position of the
glycosylation site motif. Potential glycosylation site motifs at positions
126 and 246 were found in A/Victoria/3/75-like and A/Mississippi/1/
85-like viruses, respectively. Motifs at positions 122 and 133 were
found in viruses isolated from 1999 onward; the motif at position 144
was sometimes found in viruses isolated in 1999 and was absent from
subsequent strains.
FIG. 4. HAE cultures were treated with neuraminidase from Vibrio
cholerae for 3 h at 37°C (A and B). Control cultures (C and D) were
incubated with serum-free DMEM only. Cells were infected via the
apical surface with human H3N2 influenza virus A/England/26/99 or
PIV3-GFP and fixed at 24 h postinfection. Influenza virus-infected
cultures were stained with mouse anti-influenza A nucleoprotein an-
tibody, followed by goat anti-mouse IgG conjugated to Alexa Fluor
488. Representative photomicrographs of neuraminidase-treated HAE
cultures infected with influenza virus (A) and PIV3-GFP (B) and
control cultures infected with influenza virus (C) and PIV3-GFP
(D) are shown.
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To determine whether this marked change in receptor binding
affected virus cell tropism in HAE, we determined the propor-
tion of ciliated and nonciliated cells infected by an older virus
(1969) and by more-recent (1999 to 2000) virus strains (Fig. 3).
Interestingly, we observed a trend in cell type tropism in which
the older H3N2 strain infected proportionally more ciliated
cells than nonciliated cells, whereas recent viruses showed an
increasing specificity for nonciliated cells.
Entry of human influenza viruses into HAE cells is not
affected by depletion of cell surface sialic acid. Both parain-
fluenza virus 3 (PIV3) and influenza virus utilize cell surface
sialic acid as receptors for entry into human airway cells. The
entry of PIV3 is exquisitely sensitive to removal of cell surface
sialic acid by treatment of HAE with broad-spectrum neura-
minidases (43). We investigated the efficiency of entry of hu-
man influenza virus A/England/26/99 following pretreatment
of HAE with a broad-spectrum neuraminidase from Vibrio
cholerae (NA III), which cleaves sialic acid residues with -2,3,
-2,6, and -2,8 linkages, and surprisingly found little effect on
influenza virus entry although PIV3 infection under identical
conditions was abolished (Fig. 4). Although lectin staining re-
vealed that sialic removal is not complete following NA treat-
ment (data not shown), this result demonstrates that unlike
PIV3, influenza virus can enter cells which are relatively de-
pleted in cell surface sialic acid.
Avian influenza viruses infect HAE cells. To determine
whether avian strains of influenza A virus could infect human
airway cells, as might happen at the start of a pandemic, the
apical surfaces of HAE cultures were exposed to equal titers
(as determined by a TCID50 assay of MDCK cells) of two
different subtypes of avian influenza A virus, A/Duck/Singa-
pore/5/97 (H5N3) and A/Duck/England/62 (H4N6), or the hu-
man strain A/England/26/99 (H3N2) for comparison. Follow-
ing infection and incubation, the cultures were fixed and
stained en face with anti-influenza A NP antibody, which rec-
ognizes nucleoprotein from both the avian and human viruses.
FIG. 5. HAE cultures were infected apically with equal titers of two
different subtypes of avian influenza virus A/Duck/Singapore/5/97 (H5N3)
(A) and A/Duck/England/62 (H4N6) (B) and a human influenza virus A/En-
gland/26/99 (H3N2) (C) for 1 h at 37°C. Virus was removed, and after a
further 23-h incubation, the cultures were fixed with methanol/acetone (50:
50) and stained en face with anti-influenza A nucleoprotein antibody and goat
anti-mouse conjugated to Alexa Fluor 488. Representative fluorescent pho-
tomicrographs of the stained cultures are shown. Avian influenza viruses
A/Duck/Singapore/5/97 (D) and A/Duck/England/62 (E) were found to be
localized exclusively in ciliated cells by costaining with rabbit anti-avian influ-
enza A nucleoprotein (green) and mouse monoclonal -tubulin IV antibody
(red) to identify ciliated cells and visualization with anti-rabbit FITC and
anti-mouse Texas Red. Arrows, avian virus-infected ciliated cells.
FIG. 6. HAE cultures were infected with human H3N2 influenza A
viruses isolated in England between 1969 and 2000 (A/England/878/69,
A/England/26/99, and A/England/24/00) and with avian H5N3 influ-
enza A strain A/Duck/Singapore/5/97 at an MOI of 0.1. Virus released
from the apical surface of infected cultures at 6 and 24 h postinfection
was quantified by a TCID50 assay of MDCK cells. Representative
results from two independent experiments are shown. Viral titers are
expressed as log TCID50/100 l.
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At 6 h postinfection, little or no viral antigen was detected in
the avian virus-infected cells. However, after 23 h of incuba-
tion, we found clear evidence of avian virus infection of HAE
(Fig. 5A and B), although NP staining of avian virus-infected
cultures was less widespread than that of human virus-infected
cultures (Fig. 5C). Only 5% of the HAE cells were infected by
A/Duck/Singapore/5/97 virus and 9% were infected by
A/Duck/England/62 virus compared to 12.5% of the cells in-
fected by the human virus under these conditions. The avian
virus-infected cultures showed a more punctuate cultures pat-
tern of staining in comparison to the diffuse staining of the
human virus-infected cultures, suggesting that the avian virus
infection was limited to a focal point of initial infection (Fig.
5A to C).
Cell tropism of avian influenza viruses in HAE. Histological
cross sections of HAE fixed at 6 h and 24 h postinfection with
avian influenza viruses A/Duck/Singapore/5/97 (H5N3), A/Duck/
England/62 (H4N6), and A/Duck/Ukraine/1/63 (H3N8) were ex-
amined for the presence of viral nucleoprotein. Viral nucleopro-
tein was clearly observed in the cell nucleus and distributed
through the cytoplasm to the apical cell surface in cultures fixed at
24 h postinfection only (Fig. 5D and E). No avian virus antigen
was detected at 6 h postinfection, in contrast to human virus-
infected cells which were clearly detected at early times postin-
fection (Fig. 2), suggesting that human viruses replicated at higher
levels than avian viruses in this culture model. Using -tubulin IV
counterstaining, we observed that avian influenza A viruses al-
most exclusively infected the ciliated cell types (Fig. 3 and 5D
and E).
Influenza A viruses replicate productively in HAE. HAE
cultures were infected apically with equal titers (MOI, 0.1) of
old (1969) and modern (1999 to 2000) human H3N2 viruses or
with the avian influenza A virus A/Duck/Singapore/5/97, and
supernatants were collected from the apical and basolateral
compartments of the infected HAE cultures at 6 and 24 h
postinfection to measure nascent virus release. Hemagglutina-
tion assays with turkey red blood cells indicated that virus was
released from the apical but not the basolateral surface of all
of the infected cultures (data not shown). TCID50 assays of
MDCK cells were used to calculate virus titers released from
the apical surface (Fig. 6). All viruses replicated in HAE,
although recently isolated viruses (A/England/26/99 and A/En-
gland/24/00) produced titers 2 to 3 logs lower than that of the
older H3N2 strain (A/England/878/69). Avian virus replication
was slower than replication for the human viruses. Only low
virus titers were detected at 6 h postinfection, but by 24 h,
avian virus titers had accumulated to a level similar to that of
the recent human strains (Fig. 6). Accordingly, it was difficult
to find avian influenza virus particles in thin sections fixed at
12 h postinfection and analyzed by electron microscopy. One
small patch of budded virus was evident after we scanned many
fields (Fig. 7A). In contrast, released human influenza virus
particles were readily detected above the surfaces of cells fixed
at this time (Fig. 7B). The released virus morphology was
predominantly spherical, and virions were found largely at the
level of microvillus tips (Fig. 7C).
DISCUSSION
In this study, using well-differentiated human airway tra-
cheobronchial epithelial cells, we have demonstrated that in-
fluenza A viruses isolated from human and avian species show
a general cell tropism which reflects the predominant distribu-
tion of appropriate sialic acid receptors on nonciliated and
ciliated cells, respectively. A human influenza A virus isolated
during the pandemic of 1968 to 1969 infected a high propor-
tion of ciliated cells, and avian viruses almost exclusively infect
this cell type, which displays mainly the preferred avian virus
receptor -2,3-linked sialic acid. Early in the adaptation of the
FIG. 7. HAE cultures were infected with avian (A/Duck/Singapore/
5/97) and human (A/England/26/99) influenza A viruses at an MOI of
0.1 and fixed at 12 h postinfection with perfluorocarbon-osmium tet-
roxide that preserves the air-surface microenvironment of HAE. Sec-
tions were processed for electron microscopy and analyzed. For the
avian influenza strain, only one small cluster of budded virus particles
was visible after many fields were scanned (A). Released human in-
fluenza virus particles were readily detected above the surfaces of cells.
The released virus morphology was predominantly spherical (B), and
virions were found to be accumulated at the level of microvillar tips
(C). Scale bars are shown for each panel. Arrows, microvilli; small
arrowheads, virus particles; large arrowhead in panel C, cilia.
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virus to humans, it must acquire the ability to bind -2,6-linked
sialic acid receptors as this is the predominant sialic acid spe-
cies in the human airway. However, the presence of lesser
amounts of -2,3-linked sialic acid receptors perhaps aids the
initial crossover from avian species. Infection of a mixture of
cell types by the pandemic-era virus A/England/69 might re-
flect binding to -2,3-linked sialic acid on ciliated cells and
perhaps also binding to -2,6-linked sialic acid receptors dis-
tributed across both cell types. Recent H3N2 viruses tended to
infect nonciliated cells, reflecting the predominance of the
preferred human virus receptor -2,6-linked sialic acid on this
cell type. The trend from infection of ciliated cells toward
increasing infection of nonciliated cells as the virus evolves in
humans might reflect either a decreased affinity for -2,3-
linked sialic acid on ciliated cells or preferential use of -2,6-
linked sialic acid found on nonciliated cell types.
Our results show that the removal of a significant proportion
of sialic acid by treatment with a broad-spectrum neuramini-
dase still allowed influenza infection even when PIV3 infection
was completely abrogated. Similarly, using a primary culture of
human bronchial epithelial cells, it was recently shown that
sialidase treatment reduced infection by human PIV1 but not
by influenza virus (15). These data suggest that influenza vi-
ruses require only a minimal amount of sialic acid to achieve
cellular entry or that influenza virus and PIV3 use sialic acids
on different molecules that are differentially cleaved by exog-
enous neuraminidase. Recent influenza virus A/England/26/99
infects a mixture of cell types in HAE (Fig. 3A), while PIV3 is
restricted to ciliated cells (43). The different infection profiles
for each virus following neuraminidase treatment may reflect
the relative accessibility of ciliated and nonciliated cells for
exogenous neuraminidase. If sialic acid is more effectively
stripped from ciliated cells than from nonciliated cells, this will
abrogate PIV3 infection while influenza virus may be less af-
fected, as it can infect both ciliated and nonciliated cell types.
As the H3N2 subtype has circulated in humans over the last
four decades, HA has constantly evolved via antigenic drift as
viruses carrying mutations in antigenic sites on the globular
head of HA are positively selected. Changes in antigenic sites
can also affect the receptor interaction. In particular, the ad-
dition of carbohydrate chains to asparagine residues in the
vicinity of the receptor binding pocket can obscure sialic acid
access and may influence the nature of the sialic acid interac-
tion. Modern H3N2 viruses carry four or five new potential
glycosylation sites on the globular head of HA compared to a
pandemic-era virus such as A/England/69 (Fig. 3B). Recently
isolated viruses with greater numbers of potential glycosylation
sites are known to have reduced binding to sialic acid on red
blood cells (37) and might therefore have a weaker interaction
with sialic acid residues in the airway. HAE cells accurately
recapitulate human airway cellular morphology and the highly
complex glycocalyx layer; however, the presentation of sialic
acid on different cell types and the accessibility of cell surface
sialic acid for the viral receptor binding site are poorly under-
stood. In addition, there are secreted soluble sialylated mole-
cules in the airway, including mucins known to carry high levels
of -2,3-linked sialic acid (3), and these may also drive evolu-
tion of HA receptor binding by acting as decoy receptors (19).
The heterogeneity of sialic acid expression in the human
population is not known, and although we found consistent
patterns of sialic acid expression on different HAE cell types,
some variation has been reported for other similar models
(21). Different culture conditions in otherwise similar models
may lead to various degrees of terminal glycosylation on cell
surface glycoconjugates. Sialic acid expression may also de-
pend upon age or degree of differentiation of the cell. Further,
sialyl transferases have been shown to be upregulated during
inflammation (16), and this factor may influence the range of
expression in a particular cell model depending upon the
source of the primary cells. Levels of expression of a particular
sialic acid species may be a factor in virus transmission, host
range restriction, and adaptation of influenza virus to infection
of humans (11, 41).
The present study agrees with that of Matrosovich et al. (21)
in that we clearly show -2,3-linked sialic acid on the surface of
ciliated cells. However, we also found some staining of ciliated
cells with the lectin for -2,6-linked sialic acid, indicating the
presence of receptors for both avian and human viruses on
ciliated cells. Furthermore, viral antigen was found to be lo-
calized in ciliated cells in both avian and human virus infec-
tions of HAE, suggesting that viruses from both species are
capable of entering this cell type in the human airway epithe-
lium. A complete segregation of cell types initially infected by
avian and human viruses has been reported previously (21),
and in agreement with this, we also found avian viruses to be
almost exclusively in ciliated cells. However, the wider distri-
bution of -2,6-linked sialic acid expression seen in our model,
which was confirmed in histological sections of excised human
airway tissue, is reflected in the observed mixed cell tropism of
the human viruses. The potential for coinfection of ciliated
cells suggested by these data provides a possible mechanism
for generation of genetic reassortants of viruses from different
origins during infection of humans.
Conflicting reports in the literature show human influenza
viruses to be exclusively localized in ciliated (6) or nonciliated
(21) cells. The earlier study was made with laboratory variants
of pandemic-era H3N2 viruses passaged in the allantoic sac of
embryonated chicken eggs, and it has since been shown that
this method of cultivation will select receptor binding mutants
with avian-like characteristics due to the predominance of
-2,3-linked sialic acid receptors in this egg compartment (10,
12). It is unsurprising, therefore, that these viruses exclusively
infected ciliated cells, similar to avian viruses, as shown here
and previously (21). The present study, in common with that of
Matrosovich and colleagues (21), used human viruses mini-
mally passaged in cell culture to maintain the HA sequence
and characteristics of the original clinical isolate (13) and
should more accurately report the characteristics of the human
viruses studied.
In contrast to other respiratory viruses also studied in this
HAE cell model, such as respiratory syncytial virus and PIV3
(43, 44), human influenza virus infection proceeded to com-
plete destruction of the culture, loss of cilial beat, and shedding
of the columnar epithelial cells generally within 48 h of infec-
tion (44; data not shown). HAE cultures were infectible with
avian influenza viruses, even using a low-inoculum titer (MOI,
1); however, avian virus antigen was not detected at early
times (6 h) postinfection, in contrast to human virus antigen
which was abundant at this time. Further, HAE cultures in-
fected with avian viruses showed considerably less cytopathic
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effect than human viruses at 48 h postinfection, again suggest-
ing that avian viruses are less able to spread. This perhaps
reflects the wider distribution of -2,6-linked sialic acid, the
preferred human virus receptor, and/or the attenuated repli-
cation levels of avian viruses in HAE and the ability of the
human viruses to infect a mixture of cell types.
Avian influenza virus infection of humans was first described
relatively recently during the outbreak of highly pathogenic
avian influenza H5N1 virus in 1997 and subsequently in 2004
to 2005 (5, 7, 29, 36, 38). The cellular and tissue tropism of
the avian virus in humans is poorly defined, although a recent
study of autopsy material from an H5N1-infected patient sug-
gested that despite a generalized clinical manifestation, viral
replication may be restricted to the lung and intestine (39).
Further, staining for viral antigen was shown exclusively in
nuclei of alveolus-lining cells, reported to be type II pneumo-
cytes, while there was no antigen in the columnar epithelium at
the time of autopsy (17 days following onset of illness), possibly
suggesting that in contrast to infection with human influenza
virus, the major cellular site of avian viral replication is the
pneumocyte. Two recent studies using human tissue suggest
that expression of the avian virus receptor -2,3-linked sialic
acid is abundant in the lower respiratory tract compared to that
in the upper respiratory tract. Correspondingly, H5N1 virus
was shown to attach to ciliated cells in bronchiolar sections of
human lung and to type II pneumocytes in the alveolus but not
to the trachea (35, 40). In the current study, ciliated cells
derived from bronchial airway epithelium displayed -2,3-linked
sialic acid receptors and were infected by avian viruses. The study
of the distribution of sialic acid receptors throughout the human
airway epithelia is important in allowing predictive analysis of the
threat posed by emerging avian influenza viruses.
PIV3 F glycoprotein has been found to be localized in the
membranes of the cilial shafts of HAE cells, suggesting that
virus budding and shedding may occur from these structures
(43). In the present study of influenza virus-infected HAE
cells, viral antigen was not detected in cilial shafts although it
was extensively present throughout the cytoplasm and at the
apical cell surface. Similarly, observation of infected cultures
by electron microscopy at 12 h postinfection showed virus
accumulating at the tips of the microvilli below the level of the
cilial shafts. HAE cells display sialic acid at the apical cell
surface in the region of the microvilli, and lectin staining was
not observed on the cilial shaft. This distribution of sialic acid
highlights the requirement for a balance between influenza
virus hemagglutinin and neuraminidase activities (42). If the
virus is released into a region where the viral receptor is
present at a high density, then there is an essential requirement
for a balanced neuraminidase function to enable virus release
and spread (28). The location of budding reflects the difference in
necessity for neuraminidase between influenza virus and PIV3. In
contrast to influenza virus, PIV3 may rely less on neuraminidase
function as it buds from a region in which little sialic acid is
displayed.
The morphology of influenza viruses budding from HAE
was predominantly spherical, even when viruses with a strongly
filamentous phenotype in MDCK cells were observed (8; data
not shown). Whether all influenza viruses budding from cells in
the human airway naturally show a spherical morphology re-
mains to be determined.
Well-differentiated cultures of the respiratory epithelium,
such as the HAE described here, provide an appropriate cell
model for the characterization of influenza virus infection of
humans and should drive toward a better understanding of
virus-receptor interactions, host range restrictions, and trans-
mission of this important pathogen.
ACKNOWLEDGMENTS
We thank the directors and teams of the UNC Cystic Fibrosis Cen-
ter Tissue Culture Core and the Morphology and Morphometry Core
for supplying reagents and technical expertise. Human influenza vi-
ruses were originally obtained from the Health Protection Agency
(HPA), Colindale, London, United Kingdom, and recombinant para-
influenza viruses were obtained from Peter Collins (NIAID).
C.I.T. was funded through an NIH/NHLBI Pulmonary and Critical
Care Medicine training grant (HL007106-30).
REFERENCES
1. Abe, Y., E. Takashita, K. Sugawara, Y. Matsuzaki, Y. Muraki, and S. Hongo.
2004. Effect of the addition of oligosaccharides on the biological activities
and antigenicity of influenza A/H3N2 virus hemagglutinin. J. Virol. 78:9605–
9611.
2. Abed, Y., A.-M. Bourgault, R. J. Fenton, P. J. Morley, D. Gower, I. J. Owens,
M. Tisdale, and G. Boivin. 2002. Characterization of two influenza A
(H3N2) clinical isolates with reduced susceptibility to neuraminidase inhib-
itors due to mutations in the hemagglutinin gene. J. Infect. Dis. 186:1074–
1080.
3. Baum, L. G., and J. C. Paulson. 1990. Sialyloligosaccharides of the respira-
tory epithelium in the selection of human influenza virus receptor specificity.
Acta Histochem. Suppl. 40:35–38.
4. Bean, W. J., M. Schell, J. Katz, Y. Kawaoka, C. Naeve, O. Gorman, and R. G.
Webster. 1992. Evolution of the H3 influenza virus hemagglutinin from
human and nonhuman hosts. J. Virol. 66:1129–1138.
5. Chotpitayasunondh, T., K. Ungchusak, W. Hanshaoworakul, S. Chunsuthiwat,
P. Sawanpanyalert, R. Kijphati, S. Lochindarat, P. Srisan, P. Suwan, Y.
Osotthanakorn, T. Anantasetagoon, S. Kanjanawasri, S. Tanupattarachai,
J. Weerakul, R. Chaiwirattana, M. Maneerattanaporn, R. Poolsavathitikool,
K. Chokephaibulkit, A. Apisarnthanarak, and S. F. Dowell. 2005. Human
disease from influenza A (H5N1), Thailand, 2004. Emerg. Infect. Dis. 11:
201–209.
6. Couceiro, J. N. S. S., J. C. Paulson, and L. G. Baum. 1993. Influenza virus
strains selectively recognize sialyloligosaccharides on human respiratory ep-
ithelium; the role of the host cell in selection of hemagglutinin receptor
specificity. Virus Res. 29:155–165.
7. de Jong, J. C., E. C. J. Class, A. D. M. E. Osterhaus, R. G. Webster, and
W. L. Lim. 1997. A pandemic warning? Nature 389:554.
8. Elleman, C. J., and W. S. Barclay. 2004. The M1 matrix protein controls the
filamentous phenotype of influenza A virus. Virology 321:144–153.
9. Gagneux, P., M. Cheriyan, N. Hurtado-Ziola, E. C. M. Brinkman van der
Linden, D. Anderson, H. McClure, A. Varki, and N. M. Varki. 2003. Human-
specific regulation of 2-6-linked sialic acids. J. Biol. Chem. 278:48245–
48250.
10. Gambaryan, A. S., J. S. Robertson, and M. N. Matrosovich. 1999. Effects of
egg-adaptation on the receptor-binding properties of human influenza A and
B viruses. Virology 258:232–239.
11. Ito, T. 2000. Interspecies transmission and receptor recognition of influenza
A viruses. Microbiol. Immunol. 44:423–430.
12. Ito, T., Y. Suzuki, A. Takada, A. Kawamoto, K. Otsuki, H. Masuda, M.
Yamada, T. Suzuki, H. Kida, and Y. Kawaoka. 1997. Differences in sialic
acid-galactose linkages in the chicken egg amnion and allantois influence
human influenza virus receptor specificity and variant selection. J. Virol.
71:3357–3362.
13. Katz, J. M., M. Wang, and R. G. Webster. 1990. Direct sequencing of the HA
gene of influenza (H3N2) virus in original clinical samples reveals sequence
identity with mammalian cell-grown virus. J. Virol. 64:1808–1811.
14. Kawaoka, Y., S. Krauss, and R. G. Webster. 1989. Avian-to-human trans-
mission of the PB1 gene of influenza A viruses in the 1957 and 1968 pan-
demics. J. Virol. 63:4603–4608.
15. Kogure, T., T. Suzuki, T. Takahashi, D. Miyamoto, K. I. P. J. Hidari, C.-T.
Guo, T. Ito, Y. Kawaoka, and Y. Suzuki. 2006. Human trachea primary
epithelial cells express both sialyl(2–3)Gal receptor for human parainflu-
enza virus type 1 and avian influenza viruses, and sialyl(2–6)Gal receptor
for human influenza viruses. Glycoconj. J. 23:101–106.
16. Lamblin, G., S. Degroote, J.-M. Perini, P. Delmotte, A. Scharfman, M.
Davril, J.-M. Lo-Guidice, N. Houdret, V. Dumur, A. Klein, and P. Roussel.
2001. Human airway mucin glycosylation: a combinatory of carbohydrate
determinants which vary in cystic fibrosis. Glycoconj. J. 18:661–684.
VOL. 80, 2006 INFLUENZA VIRUS INFECTION OF HUMAN AIRWAY EPITHELIUM 8067
17. Macken, C., H. Lu, J. Goodman, and L. Boykin. 2001. The value of a
database in surveillance and vaccine selection, p. 103–106. In A. D. M. E.
Osterhaus, N. Cox, and A. W. Hampson (ed.), Options for the control of
influenza IV. Elsevier Science, Amsterdam, The Netherlands.
18. Martz, E. 2002. Protein Explorer: easy yet powerful macromolecular visual-
ization. Trends Biochem. Sci. 27:107–109.
19. Matrosovich, M., and H.-D. Klenk. 2003. Natural and synthetic sialic acid-
containing inhibitors of influenza virus receptor binding. Rev. Med. Virol.
13:85–97.
20. Matrosovich, M., A. Tuzikov, N. Bovin, A. Gambaryan, A. Klimov, M. R.
Castrucci, I. Donatelli, and Y. Kawaoka. 2000. Early alterations of the
receptor-binding properties of H1, H2, and H3 avian influenza virus hem-
agglutinins after their introduction into mammals. J. Virol. 74:8502–8512.
21. Matrosovich, M. N., T. Y. Matrosovich, T. Gray, N. A. Roberts, and H.-D.
Klenk. 2004. Human and avian influenza viruses target different cell types in
cultures of human airway epithelium. Proc. Natl. Acad. Sci. USA 101:4620–
4624.
22. Medeiros, R., N. Escriou, N. Naffakh, J.-C. Manuguerra, and S. van der
Werf. 2001. Hemagglutinin residues of recent human A (H3N2) influenza
viruses that contribute to the inability to agglutinate chicken erythrocytes.
Virology 289:74–85.
23. Mochalova, L., A. Gambaryan, J. Romanova, A. Tuzikov, A. Chinarev, D.
Katinger, H. Katinger, A. Egorov, and N. Bovin. 2003. Receptor-binding
properties of modern human influenza viruses primarily isolated in Vero and
MDCK cells and chicken embryonated eggs. Virology 313:473–480.
24. Morishita, T., S. Kobayashi, T. Miyake, Y. Ishihara, S. Nakajima, and K.
Nakajima. 1993. Host-specific hemagglutination of influenza A (H1N1) vi-
rus. Microbiol. Immunol. 37:661–665.
25. Naeve, C. W., V. S. Hinshaw, and R. G. Webster. 1984. Mutations in the
hemagglutinin receptor-binding site can change the biological properties of
an influenza virus. J. Virol. 51:567–569.
26. Nobusawa, E., H. Ishihara, T. Morishita, K. Sato, and K. Nakajima. 2000.
Change in receptor-binding specificity of recent human influenza A viruses
(H3N2): a single amino acid change in hemagglutinin altered its recognition
of sialyloligosaccharides. Virology 278:587–596.
27. Ohuchi, M., R. Ohuchi, A. Feldmann, and H.-D. Klenk. 1997. Regulation of
receptor binding affinity of influenza virus hemagglutinin by its carbohydrate
moiety. J. Virol. 71:8377–8384.
28. Palese, P., K. Tobita, M. Ueda, and R. W. Compans. 1974. Characterization
of temperature sensitive influenza virus mutants defective in neuraminidase.
Virology 61:397–410.
29. Peiris, J. S., W. C. Yu, C. W. Leung, C. Y. Cheung, W. F. Ng, J. M. Nicholls,
T. K. Ng, K. H. Chan, S. T. Lai, W. L. Lim, K. Y. Yuen, and Y. Guan. 2004.
Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet
363:617–619.
30. Pickles, R. J., D. McCarty, H. Matsui, P. J. Hart, S. H. Randell, and R. C.
Boucher. 1998. Limited entry of adenovirus vectors into well-differentiated
airway epithelium is responsible for inefficient gene transfer. J. Virol. 72:
6014–6023.
31. Rogers, G. N., and J. C. Paulson. 1983. Receptor determinants of human and
animal influenza virus isolates: differences in receptor specificity of the H3
hemagglutinin based on species of origin. Virology 127:361–373.
32. Rogers, G. N., J. C. Paulson, R. S. Daniels, J. J. Skehel, I. A. Wilson, and
D. C. Wiley. 1983. Single amino acid substitutions in influenza haemagglu-
tinin change receptor binding specificity. Nature 304:76–78.
33. Sauter, N. K., J. E. Hanson, G. D. Glick, J. H. Brown, R. L. Crowther, S. J.
Park, J. J. Skehel, and D. C. Wiley. 1992. Binding of influenza virus hem-
agglutinin to analogs of its cell-surface receptor, sialic acid: analysis by
proton nuclear magnetic resonance spectroscopy and X-ray crystallography.
Biochemistry 31:9609–9621.
34. Scholtissek, C., W. Rohde, V. von Hoyningen, and R. Rott. 1978. On the
origin of the human influenza virus subtypes H2N2 and H3N2. Virology
87:13–20.
35. Shinya, K., M. Ebina, S. Yamada, M. Ono, N. Kasai, and Y. Kawaoka. 2006.
Influenza virus receptors in the human airway. Nature 440:435–436.
36. Subbarao, K., A. Klimov, J. Katz, H. Regnery, W. Lim, H. Hall, M. Perdue, D.
Swayne, C. Bender, J. Huang, M. Hemphill, T. Rowe, M. Shaw, X. Xu, K.
Fukuda, and N. Cox. 1998. Characterization of an avian influenza A (H5N1)
virus isolated from a child with a fatal respiratory illness. Science 279:393–396.
37. Thompson, C. I., W. S. Barclay, and M. C. Zambon. 2004. Changes in in vitro
susceptibility of influenza A H3N2 viruses to a neuraminidase inhibitor drug
during evolution in the human host. J. Antimicrob. Chemother. 53:759–765.
38. Tran, T. H., T. L. Nguyen, T. D. Nguyen, T. S. Luong, P. M. Pham, V. C.
Nguyen, T. S. Pham, C. D. Vo, T. Q. Le, T. T. Ngo, B. K. Dao, P. P. Le, T. T.
Nguyen, T. L. Hoang, V. T. Cao, T. G. Le, D. T. Nguyen, H. N. Le, K. T.
Nguyen, H. S. Le, V. T. Le, C. Dolecek, T. T. Tran, M. de Jong, C. Schultsz,
P. Cheng, W. Lim, P. Horby, J. Farrar, and the World Health Organization
International Avian Influenza Investigation Team. 2004. Avian influenza A
(H5N1) in 10 patients in Vietnam. N. Engl. J. Med. 350:1179–1188.
39. Uiprasertkul, M., P. Puthavathana, K. Sangsiriwut, P. Pooruk, K. Srisook,
M. Peiris, J. M. Nicholls, K. Chokephaibulkit, N. Vanprapar, and P.
Auewarakul. 2005. Influenza A H5N1 replication sites in humans. Emerg.
Infect. Dis. 11:1036–1041.
40. van Riel, D., V. J. Munster, E. de Wit, G. F. Rimmelzwaan, R. A. M.
Fouchier, A. D. M. E. Osterhaus, and T. Kuiken. 2006. H5N1 virus attach-
ment to lower respiratory tract. Science 312:399.
41. Vines, A., K. Wells, M. Matrosovich, M. R. Castrucci, T. Ito, and Y. Kawaoka.
1998. The role of influenza A virus hemagglutinin residues 226 and 228 in
receptor specificity and host range restriction. J. Virol. 72:7626–7631.
42. Wagner, R., M. Matrosovich, and H.-D. Klenk. 2002. Functional balance
between haemagglutinin and neuraminidase in influenza virus infections.
Rev. Med. Virol. 12:159–166.
43. Zhang, L., A. Bukreyev, C. I. Thompson, B. Watson, M. E. Peeples, P. L.
Collins, and R. J. Pickles. 2005. Infection of ciliated cells by human parain-
fluenza virus type 3 in an in vitro model of human airway epithelium. J. Virol.
79:1113–1124.
44. Zhang, L., M. E. Peeples, R. C. Boucher, P. L. Collins, and R. J. Pickles.
2002. Respiratory syncytial virus infection of human airway epithelial cells is
polarized, specific to ciliated cells, and without obvious cytopathology. J. Vi-
rol. 76:5654–5666.
8068 THOMPSON ET AL. J. VIROL.
